Cavs’ Thompson Hit With 25-game Drug Suspension | The Sporting Base
[google-translator]

Cavs’ Thompson hit with 25-game drug suspension

January 24, 2024

Cavs’ Thompson hit with 25-game drug suspension

Cleveland Cavaliers big Tristan Thompson has been suspended for 25 games without pay after violating the league’s Anti-Drug Program.

Thompson tested positive for ibutamoren and SARM LGD-4033, the league announced.

The 32-year-old signed a one-year deal with Cleveland this past summer after finishing last season with the Lakers.

In the absence of Evan Mobley, Thompson has proven to be a handy option for head coach J.B. Bickerstaff having averaged 12.4 minutes per game across 36 games.

Thompson was drafted by the Cavs back in 2011 and spent nine seasons with the franchise before parting ways with them at the end of the 2019/20 season.

He started all 21 games of Cleveland’s 2016 title run averaging 10.3 ppg and 10.1 rpg to help drag them back from a 3-1 deficit to overcome the Warriors in the Finals.


Fill In The Form Below To Receive Our NBA News & Tips Via Email!

  • This field is for validation purposes and should be left unchanged.

Tell Us What You Think Below

March 7, 2026

Grizzlies center Zach Edey out for the season

Another Canadian is out with a significant injury in the National Basketball Association We have recently talked about London, Ontario's Shaedon Sharpe of the Portland Trail Blazers (broken leg), Read More

March 7, 2026

Opinion: Surprising that Bulls were an 11.5 point underdog against the Suns

The Chicago Bulls defeated the Phoenix Suns 105-103 on Thursday The Suns were a 115 point underdog, and at first glance one may be surprised that the spread actually reached double digits Prior to Read More

March 7, 2026

Shohei Ohtani delivers with WBC Grand Slam in Japan win over Chinese Taipei

The World Baseball Classic is continuing in Tokyo After Australia came through with two victories over the last two days, we saw greatness from Japan on Friday The Japanese player who came through Read More